BCL2L1 and neoplasm: In addition, STC1 also activates ERK and JNK pathway promoting inhibitor of apoptosis proteins (BcL-2 and BcL-xl) and inhibits the expression of pro-apoptotic proteins (Bax, Bak and Bid) for tumor survival [41].